Trial Profile
Phase III trial of carfilzomib in patients with newly-diagnosed multiple myeloma.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 17 Jan 2013
Price :
$35
*
At a glance
- Drugs Carfilzomib (Primary)
- Indications Multiple myeloma
- Focus Registrational; Therapeutic Use
- 17 Jan 2013 New trial record